- Olanzapine and fecal microbiota transplantation from antipsychotic-naïve schizophrenia patients alter metabolic profiles differentially in male and female mice.
Raghunath Singh,Giada De Palma,Sandra Pereira,Kristoffer Panganiban,Sally Wu,Laurie Hamel,Thomas D. Prevot,David C. Wright,Daniel Mueller,Gary Remington,Sri Mahavir Agarwal,Elena F. Verdu,Premysl Bercik,Margaret Hahn
DOI: https://doi.org/10.1016/j.psyneuen.2023.106849
IF: 4.693
2024-02-01
Psychoneuroendocrinology
Abstract:Giada De Palma, Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada; Sandra Pereira, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Kristoffer Panganiban, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Sally Wu, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Laurie Hamel, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Thomas D. Prevot, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, ON, Canada;David C. Wright, Faculty of Education, School of Kinesiology, and Faculty of Land and Food Systems, The University of British Columbia, Vancouver, BC, Canada; Daniel Mueller, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, ON, Canada; Gary Remington, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Sri Mahavir Agarwal, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Elena F. Verdu, Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada; Premysl Bercik, Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada; Margaret Hahn, Schizophrenia Division, The Centre for Addiction and Mental Health (CAMH), Toronto, Canada. Background Emerging evidence suggests the role of gut microbiome (GMB) in the pathogenesis of schizophrenia (SCZ) and antipsychotic-induced metabolic perturbations. In the present study, we investigated the role of GMB in metabolic alterations associated with SCZ and olanzapine (a prototype antipsychotic) treatment using human fecal microbiota transplantation (FMT) in mice. Methods FMT from antipsychotic-naïve SCZ patients (SCZ-FMT) and sex-BMI matched healthy controls (HC-FMT) were performed in 5-6 weeks old male and female germ-free C57BL/6 mice. At 10-12 weeks of age, mice were given an irradiated high-fat diet (HFD) with or without olanzapine for six weeks. Weekly food intake and body weight were monitored and an intraperitoneal glucose tolerance test (IPGTT) was performed in the last week. Circulating concentrations of glucose, insulin and free fatty acids (FFA) were measured. Homeostatic model assessment for insulin resistance (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI) were calculated to assess insulin sensitivity. Results Female SCZ-FMT recipient mice showed significantly decreased area under the curve in IPGTT compared to HC-FMT recipient female mice (p=0.0159), irrespective of olanzapine treatment. This was associated with a significantly increased fasting insulin levels (p=0.0003), increased HOMA-IR (p=0.0005), and decreased QUICKI (p=0.0004) in female SCZ-FMT recipient mice, regardless of olanzapine treatment. Furthermore, SCZ-FMT recipient mice, regardless of sex or olanzapine treatment, showed significantly decreased serum FFA levels, which could indicate reduced lipolysis. #66 - Conclusion These preliminary findings suggest that GMB could be a predisposing factor contributing to the intrinsic risk of developing type 2 diabetes associated with SCZ in females.
neurosciences,endocrinology & metabolism,psychiatry